Cytokines and chemokines: Roles in the pathophysiology and therapy of ischemia and reperfusion injury

Current Opinion in Organ Transplantation

Volumn 9, Issue 2, 2004, Pages 139-144

  Araki, Motoo ^a   Schenk, Austin D ^a   Fairchild, Robert L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemokines; Cytokines; Ischemia and reperfusion injury; Macrophages; Neutrophils

Indexed keywords

EID: 35848933471     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000127627.94212.76     Document Type: Review

References (43)

1. Yokota N, Burne-Taney M, Racusen L, et al.: Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2003, 285:F319-F325.
2. Welborn MB 3rd, Moldawer LL, Seeger JM, et al.: Role of endogenous interleukin-10 in local and distant organ injury after visceral ischemia-reperfusion. Shock 2003, 20:35-40.
3. Kato A, Okaya T, Lentsch AB: Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury. Hepatology 2003, 37:304-312.
4. Giomarelli P, Scolletta S, Borrelli E, et al.: Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg 2003, 76:117-123.
5. Farivar AS, Krishnadasan B, Naidu BV, et al.: Endogenous interleukin-4 and interleukin-10 regulate experimental lung ischemia reperfusion injury. Ann Thorac Surg 2003, 76:253-259.
6. Souza DG, Guabiraba R, Pinho V, et al.: IL-1-driven endogenous IL-10 production protects against the systemic and local acute inflammatory response following intestinal reperfusion injury. J Immunol 2003, 170:4759-4766.
7. Sharma M, Ganguly NK, Chaturvedi G, et al.: Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery. Mol Cell Biochem 2003, 247:23-30.
8. Sanchez RN, Chan CK, Garg S, et al.: Interleukin-6 in retinal ischemia reperfusion injury in rats. Invest Ophthalmol Vis Sci 2003, 44:4006-4011.
9. Krizanac-Bengez L, Kapural M, Parkinson F, et al.: Effects of transient loss of shear stress on blood-brain barrier endothelium: role of nitric oxide and IL-6. Brain Res 2003, 977:239-246.
10. Zagorski J, Debelak J, Gellar M, et al.: Chemokines accumulate in the lungs of rats with severe pulmonary embolism induced by polystyrene microspheres. J Immunol 2003, 171:5529-5536.
11. Inoue K, Suzuki S, Kubo H, et al.: Effects of rewarming on nuclear factorkappa B and interleukin 8 expression in cold-preserved alveolar epithelial cells. Transplantation 2003, 76:409-415.
12. Naidu BV, Krishnadasan B, Farivar AS, et al.: Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2003, 126:200-207.
13. Rao JN, Clark SC, Ali S, et al.: Improvements in lung compliance after pulmonary transplantation: correlation with interleukin 8 expression. Eur J Cardiothorac Surg 2003, 23:497-502.
14. Popivanova BK, Koike K, Tonchev AB, et al.: Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion. Brain Res 2003, 970:195-204.
15. Riaz AA, Schramm R, Sato T, et al.: Oxygen radical-dependent expression of CXC chemokines regulate ischemia/reperfusion-induced leukocyte adhesion in the mouse colon. Free Radic Biol Med 2003, 35:782-789.
16. Fiane AE, Videm V, Lingaas PS, et al.: Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 2003, 108:849-856.
17. de Vries B, Kohl J, Leclercq WK, et al.: Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 2003, 170:3883-3889.
18. de Vries B, Matthijsen RA, Wolfs TG, et al.: Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 2003, 75:375-382.
19. Moench C, Uhrig A, Lohse AW, Otto G: The role of monocyte chemoattractant protein-1 in orthotopic liver transplantation. Transplant Proc 2003, 35:1452-1455.
20. Lahat N, Rahat MA, Ballan M, et al.: Hypoxia reduces CD80 expression on monocytes but enhances their LPS-stimulated TNF-alpha secretion. J Leukoc Biol 2003, 74:197-205.
21. Kajihara N, Morita S, Nishida T, et al.: Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation. Circulation 2003, 108(Suppl 1): II213-II218.
22. Chen Y, Hallenbeck JM, Ruetzler C, et al.: Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 2003, 23:748-755.
23. DaCosta ML, Yao Z, MacPherson BC, et al.: Brief hypoxia conditions monocytes to protect reperfused cardiocytes against cell death via the CD11b receptor. J Heart Lung Transplant 2003, 22:979-985.
24. Frangogiannis NG, Mendoza LH, Ren G, et al.: MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am J Physiol Heart Circ Physiol 2003, 285:H483-H492.
25. Ke B, Shen XD, Lassman CR, et al.: Interleukin-13 gene transfer protects rat livers from antigen-independent injury induced by ischemia and reperfusion. Transplantation 2003, 75:1118-1123.
26. de Perrot M, Fischer S, Liu M, et al.: Impact of human interleukin-10 on vectorinduced inflammation and early graft function in rat lung transplantation. Am J Respir Cell Mol Biol 2003, 28:616-625.
27. Donckier V, Loi P, Closset J, et al.: Preconditioning of donors with interleukin- 10 reduces hepatic ischemia-reperfusion injury after liver transplantation in pigs. Transplantation 2003, 75:902-904.
28. Shields CJ, Winter DC, Manning BJ, et al.: Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion. Arch Surg 2003, 138:9-14.
29. Hicks AE, Nolan SL, Ridger VC, et al.: Recombinant P-selectin glycoprotein ligand-1 directly inhibits leukocyte rolling by all 3 selectins in vivo: complete inhibition of rolling is not required for anti-inflammatory effect. Blood 2003, 101:3249-3256.
30. de Vries B, Matthijsen RA, van Bijnen AA, et al.: Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol 2003, 163:47-56.
31. Calabresi L, Rossoni G, Gomaraschi M, et al.: High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ Res 2003, 92:330-337.
32. Erikson JM, Freeman GL, Chandrasekar B: Ultrasound-targeted antisense oligonucleotide attenuates ischemia/reperfusion-induced myocardial tumor necrosis factor-alpha. J Mol Cell Cardiol 2003, 35:119-130.
33. Veldhuis WB, Derksen JW, Floris S, et al.: Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J Cereb Blood Flow Metab 2003, 23:1029-1039.
34. Chen H, Li D, Saldeen T, et al.: TGF-beta 1 attenuates myocardial ischemiareperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol 2003, 284:H1612-H1617.
35. Jiang Y, Gu XP, Qiu YD, et al.: Ischemic preconditioning decreases C-X-C chemokine expression and neutrophil accumulation early after liver transplantation in rats. World J Gastroenterol 2003, 9:2025-2029.
36. Cai Z, Manalo DJ, Wei G, et al.: Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003, 108:79-85.
37. Teoh N, Leclercq I, Pena AD, Farrell G: Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003, 37:118-128.
38. Takano H, Ohtsuka M, Akazawa H, et al.: Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr Pharm Des 2003, 9:1121-1127.
39. Chen HI, Kao SJ, Wang D, et al.: Acute respiratory distress syndrome. J Biomed Sci 2003, 10:588-592.
40. Reutzel-Selke A, Zschockelt T, Denecke C, et al.: Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/re-perfusion injury and long-term graft function in renal allografts from older donors. Transplantation 2003, 75:1786-1792.
41. Muratore A, Ribero D, Ferrero A, et al.: Prospective randomized study of steroids in the prevention of ischemic injury during hepatic resection with pedicle clamping. Br J Surg 2003, 90:17-22.
42. Calvillo L, Latini R, Kajstura J, et al.: Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 2003, 100:4802-4806.
43. Yang CW, Li C, Jung JY, et al.: Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003, 17:1754-1755.